Free Trial

Amprius Technologies (NYSE:AMPX) Stock Price Down 8.1% - Time to Sell?

Amprius Technologies logo with Business Services background
Image from MarketBeat Media, LLC.

Key Points

  • Shares fell 8.1% to about $19.68 on Tuesday on slightly below-average volume, while Wall Street's consensus is a "Moderate Buy" with an average target near $19.75 and several firms raising targets to the $20–$22 range.
  • Large insider selling has occurred recently — directors have sold roughly 2.58 million shares (~$42.8M) over the last 90 days, though insiders still own about 12.8% of the company.
  • The company slightly beat quarterly estimates (EPS -$0.01 vs. -$0.04; revenue $25.23M vs. $22.91M) but remains unprofitable with a negative net margin (~60.3%), negative ROE, a negative P/E, and guidance/estimates pointing to continued negative EPS.
  • Five stocks to consider instead of Amprius Technologies.

Amprius Technologies, Inc. (NYSE:AMPX - Get Free Report) shares dropped 8.1% during trading on Tuesday . The company traded as low as $19.10 and last traded at $19.68. Approximately 8,010,195 shares changed hands during trading, a decline of 9% from the average daily volume of 8,793,667 shares. The stock had previously closed at $21.42.

Wall Street Analysts Forecast Growth

AMPX has been the topic of a number of research analyst reports. Craig Hallum raised their price target on Amprius Technologies from $17.00 to $21.00 and gave the company a "buy" rating in a report on Friday, March 6th. Roth Mkm reissued a "buy" rating and set a $20.00 price target (up from $16.00) on shares of Amprius Technologies in a report on Friday, March 6th. William Blair reissued an "outperform" rating on shares of Amprius Technologies in a report on Friday, March 6th. B. Riley Financial raised their target price on Amprius Technologies from $16.00 to $22.00 and gave the company a "buy" rating in a research note on Monday, March 9th. Finally, Weiss Ratings reaffirmed a "sell (e+)" rating on shares of Amprius Technologies in a research note on Monday, April 20th. Eight equities research analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus target price of $19.75.

Get Our Latest Analysis on Amprius Technologies

Amprius Technologies Stock Down 8.1%

The company has a 50 day moving average of $16.33 and a two-hundred day moving average of $12.94. The firm has a market cap of $2.70 billion, a P/E ratio of -57.88 and a beta of 2.20.

Amprius Technologies (NYSE:AMPX - Get Free Report) last announced its earnings results on Wednesday, March 4th. The company reported ($0.01) earnings per share for the quarter, beating the consensus estimate of ($0.04) by $0.03. Amprius Technologies had a negative return on equity of 24.29% and a negative net margin of 60.30%.The business had revenue of $25.23 million during the quarter, compared to analysts' expectations of $22.91 million. Amprius Technologies has set its FY 2026 guidance at --0.060 EPS. Research analysts expect that Amprius Technologies, Inc. will post -0.03 earnings per share for the current fiscal year.

Insider Transactions at Amprius Technologies

In related news, Director Steven Chu sold 166,632 shares of the stock in a transaction on Tuesday, March 10th. The stock was sold at an average price of $17.92, for a total value of $2,986,045.44. Following the completion of the transaction, the director owned 127,339 shares in the company, valued at $2,281,914.88. This trade represents a 56.68% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Kang Sun sold 1,500,000 shares of the stock in a transaction on Wednesday, April 1st. The shares were sold at an average price of $15.91, for a total value of $23,865,000.00. Following the completion of the transaction, the director owned 1,342,400 shares of the company's stock, valued at $21,357,584. This trade represents a 52.77% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders sold 2,579,519 shares of company stock worth $42,799,656. Corporate insiders own 12.80% of the company's stock.

Hedge Funds Weigh In On Amprius Technologies

Hedge funds and other institutional investors have recently modified their holdings of the stock. Stephens Investment Management Group LLC acquired a new position in shares of Amprius Technologies in the 3rd quarter valued at $11,392,000. Vanguard Group Inc. boosted its position in shares of Amprius Technologies by 37.0% in the 3rd quarter. Vanguard Group Inc. now owns 6,512,620 shares of the company's stock valued at $68,513,000 after purchasing an additional 1,757,395 shares during the period. SG Americas Securities LLC acquired a new position in shares of Amprius Technologies in the 4th quarter valued at $2,014,000. Calamos Advisors LLC acquired a new stake in Amprius Technologies during the 3rd quarter worth about $1,799,000. Finally, Tudor Investment Corp ET AL acquired a new stake in Amprius Technologies during the 3rd quarter worth about $7,530,000. Institutional investors and hedge funds own 5.04% of the company's stock.

About Amprius Technologies

(Get Free Report)

Amprius Technologies, Inc NYSE: AMPX is a U.S.-based developer of high-energy-density lithium-ion batteries that leverage silicon anode technology to deliver performance levels beyond conventional graphite-based cells. The company's batteries are designed to offer industry-leading gravimetric energy density, enabling longer run times and reduced weight for portable power applications. Amprius blends advanced materials science and scalable manufacturing processes to commercialize next-generation battery solutions.

At the core of Amprius' product portfolio are cylindrical and prismatic cells that employ a proprietary silicon nanowire anode, which supports high charge/discharge rates while maintaining cycle life.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Amprius Technologies Right Now?

Before you consider Amprius Technologies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amprius Technologies wasn't on the list.

While Amprius Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 7 Hottest IPOs On Wall Street’s 2026 Watchlist Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines